Ozempic Copies to Cost $14 in India as Generic GLP-1 Era Starts


At least a dozen large drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs in India, crashing prices as soon as the patent expires Friday.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *